Gilead Sciences (GILD)
$65.48
0.28 (0.43%)
GILD Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
82.10B
PE Ratio
14.58
EPS
4.49
Volume (Avg. Vol.)
7.23M
Day's Range
$64.97 - $65.89
52-Week Range
$64.63 - $87.86
Dividend & Yield
$3.00 (4.58%)
GILD Stock Predictions, Articles, and Gilead Sciences News
3 Stocks at 52-Week Lows Poised for a Powerful Rebound
Starbucks, Gilead, and Vale are three stocks at 52-week lows that show signs of recovery potential and long-term growth prospects.
Why Is Xilio Therapeutics (XLO) Stock up 168% Today?
Xilio Therapeutics stock is heading higher on Thursday with heavy trading of XLO shares after announcing a deal with Gilead.
7 Value Stocks to Buy at a 52-Week Low in March
These seven value stocks to buy all trade at low valuations, and have the potential to make big recoveries.
Gilead’s Quiet Revolution: Is GILD the Next Big Stock to Soar?
While Wall Street obsesses over weight-loss drugs, Gilead Sciences is working on life-saving treatments and GILD stock looks ready to rally.
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’
It's now time to take a look at these three biotech stocks to buy, as each one is currently within TradeSmith's "Green Zone."
Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?
Hookipa Pharma stock is rising higher on Thursday as investors react to a purchase agreement for 15 million shares of HOOK.
Why Is Compugen (CGEN) Stock Up 189% Today?
Compugen stock is up on Tuesday as investors in CGEN shares react to an exclusive licensing agreement with Gilead Sciences.
Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?
Assembly Biosciences stock is taking off with heavy trading of ASMB shares after the company announced a new collaboration agreement!
GILD Stock Alert: FDA Expands Indications for Gilead Sciences’ Veklury Covid-19 Treatment
Gilead Sciences (GILD) stock is on the move Thursday following additional FDA approval for its Veklury Covid-19 treatment.
